Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 65862-191

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 65862-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

This is a description for a pharmaceutical product containing Cyclobenzaprine Hydrochloride Tablets, manufactured by Aurobindo Pharma USA, Inc. It is a bulk package of 100 tablets, each film-coated tablet containing 5mg of Cyclobenzaprine hydrochloride USP. It is advised to be dispensed in a well-closed container and stored at 20°to 25°C with excursions permitted to 15°to 30°C. Usual adult dosages are recommended to be one tablet (5mg) three times a day. However, further information can be obtained from the accompanying product information.*

FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

FDA Label Image

Chemical Structure (Cyclobenz Str)

Not-Available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.